This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.
You May Also Be Interested In
Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
Substance Use Disorders in People with Physical and Sensory Disabilities
This resource guide presents healthcare professionals working with people living with physical and sensory disabilities with information about substance use disorders, including risk factors and warning signs. It also discusses screening, types of substance use services, and strategies for helping clients.
Guidance to States and School Systems on Addressing Mental Health and Substance Use Issues in Schools
This Joint SAMHSA-CMS informational Bulletin provides guidance to states and school systems about addressing mental health and substance use issues in schools. It provides examples of approaches for services in schools and describes some Medicaid authorities that states may use to cover services.
TIP 48: Managing Depressive Symptoms in Substance Abuse Clients During Early Recovery
This guide helps substance use counselors treat clients with symptoms of depression and substance use conditions. Program administrators will learn how to integrate depression treatment into early drug treatment. The guidelines cover screening, assessment, treatment, counseling, cultural competence, and continuing care.
Advisory: Adults With Attention Deficit Hyperactivity Disorder and Substance Use Disorders
This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
Results from the 2016 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States
This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.